The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hepatitis C Virus (HCV)-Global Market Insights and Sales Trends 2024
Synopsis
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
The global Hepatitis C Virus (HCV) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hepatitis C Virus (HCV) in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Diagnostic Centers,, are propelling Hepatitis C Virus (HCV) market. Hepatitis C Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hepatitis C Test Kit segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatitis C Virus (HCV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatitis C Virus (HCV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatitis C Virus (HCV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatitis C Virus (HCV) covered in this report include Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Abbott, Siemens Healthineers and Roche Diagnostics, etc.
The global Hepatitis C Virus (HCV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Global Hepatitis C Virus (HCV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis C Virus (HCV) market, Segment by Type:
Hepatitis C Drugs
Hepatitis C Test Kit
Global Hepatitis C Virus (HCV) market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
The global Hepatitis C Virus (HCV) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hepatitis C Virus (HCV) in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Diagnostic Centers,, are propelling Hepatitis C Virus (HCV) market. Hepatitis C Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hepatitis C Test Kit segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatitis C Virus (HCV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatitis C Virus (HCV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatitis C Virus (HCV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatitis C Virus (HCV) covered in this report include Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Abbott, Siemens Healthineers and Roche Diagnostics, etc.
The global Hepatitis C Virus (HCV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Global Hepatitis C Virus (HCV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis C Virus (HCV) market, Segment by Type:
Hepatitis C Drugs
Hepatitis C Test Kit
Global Hepatitis C Virus (HCV) market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hepatitis C Virus (HCV)
1.1 Hepatitis C Virus (HCV) Market Overview
1.1.1 Hepatitis C Virus (HCV) Product Scope
1.1.2 Hepatitis C Virus (HCV) Market Status and Outlook
1.2 Global Hepatitis C Virus (HCV) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hepatitis C Virus (HCV) Market Size by Region (2018-2029)
1.4 Global Hepatitis C Virus (HCV) Historic Market Size by Region (2018-2023)
1.5 Global Hepatitis C Virus (HCV) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hepatitis C Virus (HCV) Market Size (2018-2029)
1.6.1 North America Hepatitis C Virus (HCV) Market Size (2018-2029)
1.6.2 Europe Hepatitis C Virus (HCV) Market Size (2018-2029)
1.6.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2018-2029)
1.6.4 Latin America Hepatitis C Virus (HCV) Market Size (2018-2029)
1.6.5 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2018-2029)
2 Hepatitis C Virus (HCV) Market by Type
2.1 Introduction
2.1.1 Hepatitis C Drugs
2.1.2 Hepatitis C Test Kit
2.2 Global Hepatitis C Virus (HCV) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2018-2023)
2.2.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hepatitis C Virus (HCV) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hepatitis C Virus (HCV) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hepatitis C Virus (HCV) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hepatitis C Virus (HCV) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hepatitis C Virus (HCV) Revenue Breakdown by Type (2018-2029)
3 Hepatitis C Virus (HCV) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.2 Global Hepatitis C Virus (HCV) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2018-2023)
3.2.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hepatitis C Virus (HCV) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hepatitis C Virus (HCV) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hepatitis C Virus (HCV) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hepatitis C Virus (HCV) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hepatitis C Virus (HCV) Revenue Breakdown by Application (2018-2029)
4 Hepatitis C Virus (HCV) Competition Analysis by Players
4.1 Global Hepatitis C Virus (HCV) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2022)
4.3 Date of Key Players Enter into Hepatitis C Virus (HCV) Market
4.4 Global Top Players Hepatitis C Virus (HCV) Headquarters and Area Served
4.5 Key Players Hepatitis C Virus (HCV) Product Solution and Service
4.6 Competitive Status
4.6.1 Hepatitis C Virus (HCV) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gilead
5.1.1 Gilead Profile
5.1.2 Gilead Main Business
5.1.3 Gilead Hepatitis C Virus (HCV) Products, Services and Solutions
5.1.4 Gilead Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.1.5 Gilead Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Hepatitis C Virus (HCV) Products, Services and Solutions
5.2.4 Merck Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Hepatitis C Virus (HCV) Products, Services and Solutions
5.3.4 AbbVie Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.3.5 J&J Recent Developments
5.4 J&J
5.4.1 J&J Profile
5.4.2 J&J Main Business
5.4.3 J&J Hepatitis C Virus (HCV) Products, Services and Solutions
5.4.4 J&J Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.4.5 J&J Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 Kawin
5.6.1 Kawin Profile
5.6.2 Kawin Main Business
5.6.3 Kawin Hepatitis C Virus (HCV) Products, Services and Solutions
5.6.4 Kawin Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.6.5 Kawin Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Hepatitis C Virus (HCV) Products, Services and Solutions
5.7.4 Abbott Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 Siemens Healthineers
5.8.1 Siemens Healthineers Profile
5.8.2 Siemens Healthineers Main Business
5.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Products, Services and Solutions
5.8.4 Siemens Healthineers Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthineers Recent Developments
5.9 Roche Diagnostics
5.9.1 Roche Diagnostics Profile
5.9.2 Roche Diagnostics Main Business
5.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Products, Services and Solutions
5.9.4 Roche Diagnostics Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.9.5 Roche Diagnostics Recent Developments
5.10 altona Diagnostics
5.10.1 altona Diagnostics Profile
5.10.2 altona Diagnostics Main Business
5.10.3 altona Diagnostics Hepatitis C Virus (HCV) Products, Services and Solutions
5.10.4 altona Diagnostics Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.10.5 altona Diagnostics Recent Developments
5.11 GeneProof
5.11.1 GeneProof Profile
5.11.2 GeneProof Main Business
5.11.3 GeneProof Hepatitis C Virus (HCV) Products, Services and Solutions
5.11.4 GeneProof Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.11.5 GeneProof Recent Developments
5.12 Sansure Biotech
5.12.1 Sansure Biotech Profile
5.12.2 Sansure Biotech Main Business
5.12.3 Sansure Biotech Hepatitis C Virus (HCV) Products, Services and Solutions
5.12.4 Sansure Biotech Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.12.5 Sansure Biotech Recent Developments
5.13 Daan Gene
5.13.1 Daan Gene Profile
5.13.2 Daan Gene Main Business
5.13.3 Daan Gene Hepatitis C Virus (HCV) Products, Services and Solutions
5.13.4 Daan Gene Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.13.5 Daan Gene Recent Developments
5.14 BGI Group
5.14.1 BGI Group Profile
5.14.2 BGI Group Main Business
5.14.3 BGI Group Hepatitis C Virus (HCV) Products, Services and Solutions
5.14.4 BGI Group Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.14.5 BGI Group Recent Developments
5.15 Abiores
5.15.1 Abiores Profile
5.15.2 Abiores Main Business
5.15.3 Abiores Hepatitis C Virus (HCV) Products, Services and Solutions
5.15.4 Abiores Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.15.5 Abiores Recent Developments
5.16 ACON Biotech
5.16.1 ACON Biotech Profile
5.16.2 ACON Biotech Main Business
5.16.3 ACON Biotech Hepatitis C Virus (HCV) Products, Services and Solutions
5.16.4 ACON Biotech Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.16.5 ACON Biotech Recent Developments
5.17 Nectar Lifesciences
5.17.1 Nectar Lifesciences Profile
5.17.2 Nectar Lifesciences Main Business
5.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Products, Services and Solutions
5.17.4 Nectar Lifesciences Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.17.5 Nectar Lifesciences Recent Developments
5.18 Everlywell
5.18.1 Everlywell Profile
5.18.2 Everlywell Main Business
5.18.3 Everlywell Hepatitis C Virus (HCV) Products, Services and Solutions
5.18.4 Everlywell Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.18.5 Everlywell Recent Developments
5.19 bioLytical
5.19.1 bioLytical Profile
5.19.2 bioLytical Main Business
5.19.3 bioLytical Hepatitis C Virus (HCV) Products, Services and Solutions
5.19.4 bioLytical Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.19.5 bioLytical Recent Developments
5.20 Liferiver
5.20.1 Liferiver Profile
5.20.2 Liferiver Main Business
5.20.3 Liferiver Hepatitis C Virus (HCV) Products, Services and Solutions
5.20.4 Liferiver Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.20.5 Liferiver Recent Developments
5.21 3B BlackBio Biotech India Limited
5.21.1 3B BlackBio Biotech India Limited Profile
5.21.2 3B BlackBio Biotech India Limited Main Business
5.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Products, Services and Solutions
5.21.4 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Revenue (US$ Million) & (2018-2023)
5.21.5 3B BlackBio Biotech India Limited Recent Developments
6 North America
6.1 North America Hepatitis C Virus (HCV) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hepatitis C Virus (HCV) Market Dynamics
11.1 Hepatitis C Virus (HCV) Industry Trends
11.2 Hepatitis C Virus (HCV) Market Drivers
11.3 Hepatitis C Virus (HCV) Market Challenges
11.4 Hepatitis C Virus (HCV) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
